Table 3.
Clinical Outcome during in-hospital and 30-day follow-up in diabetic and non-diabetic patients
| DM | Non-DM | P | ||
|---|---|---|---|---|
| Subject number (n) |
237 |
73 |
164 |
NA |
| Composite MACE |
35 (14.8) |
18 (24.7) |
17 (10.4) |
0.004 |
| Cardiac death |
4 (1.7) |
2 (2.7) |
2 (1.2) |
0.770 |
| Reinfarction |
3 (1.3) |
2 (2.7) |
1 (0.6) |
0.469 |
| Repeated TVR |
3 (1.3) |
1 (1.4) |
2 (1.2) |
0.594 |
| Recurrent angina |
15 (6.3) |
9 (12.3) |
6 (3.7) |
0.025 |
| Malignant arrhythmia |
10 (4.2) |
5 (6.8) |
5 (3) |
0.320 |
| Non-cardiac death |
1 (0.4) |
0 (0) |
1 (0.6) |
0.678 |
| Non-IRA revascularization | 53 (22.4) | 27 (37) | 26 (16) | 0.001 |
Data given as mean ± SD or n (%).
MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.